Posted inBiotechnology
Could Dogs Be the Next Ally in Battling Spotted Lanternflies? New Study Suggests So
At a thriving vineyard in Maryland, an unexpected new ally in the fight against invasive pests has emerged—not among the…
Posted inBiotechnology
Plasma Proteomics Links TNFRSF Proteins to HIV Stroke
In a groundbreaking study that promises to reshape our understanding of the intersection between viral infections and cerebrovascular disease, researchers…
Posted inBiotechnology
Multiscale Shape Optimization Slashes Piping Resistance
In the ever-evolving field of engineering, fluid dynamics remains a critical discipline with profound implications across industries, from water distribution…
Posted inBiotechnology
Feeding Milestones, Comorbidities, and Growth in Preterms
In a groundbreaking study recently published in the Journal of Perinatology, researchers have unearthed critical insights into the intricate relationship…
Posted inBiotechnology
Improving Meta-Analyses in Agricultural Sustainability Still Flawed
In the evolving field of agricultural sustainability, the synthesis of knowledge through meta-analyses has become an indispensable tool for researchers…
Posted inBiotechnology
Increased Connectivity Linked to Early DLB Symptoms
New Insights into Early Dementia with Lewy Bodies: Network Connectivity Links REM Sleep Behavior Disorder and Hallucinations Recent advances in…
Posted inBiotechnology
How Biogen is transforming its pipeline with a VC mindset and an ‘entrepreneurial spirit’
From persevering with a tricky Alzheimer’s program to securing a late-stage CD38-directed antibody and posting encouraging lupus data, Biogen has…
Posted inBiotechnology
Cancer biotech Parabilis ups IPO plans to potentially record-setting $637M
Mere months after obesity biotech Kailera Therapeutics netted the biggest initial public offering the sector has ever seen, with a…
Posted inBiotechnology
Lilly moves deeper into Alzheimer’s research with AlzeCure licensing deal
Eli Lilly has signed a heavily backloaded agreement to license a gamma-secretase modulator treatment for Alzheimer's disease from AlzeCure Pharma…
Posted inBiotechnology
ADA: AZ’s oral GLP-1 shows ‘competitive efficacy’ in phase 2, setting stage for pivotal program
When looking out across the competitive GLP-1 landscape, AstraZeneca might not be the first Big Pharma name that comes to…